{"canonical":"https://abierto.us/vendors/shynianbio-inc-xukam8hmlc71","key":"XUKAM8HMLC71","name":"SHYNIANBIO INC","uei":"XUKAM8HMLC71","city":"SAN FRANCISCO","state":"CA","awards":1,"obligated":"299500.00","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"9MSP0","parent_name":"SHYNIANBIO INC","also_known_as":[],"country":"USA","actions":3,"first_action":"2024-02-13","last_action":"2025-02-19","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"299500.00"}],"places":[{"key":"CA","name":null,"awards":1,"obligated":"299500.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":1,"obligated":"299500.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"299500.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"299500.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"299500.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":1,"obligated":"299500.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N91024C00004_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91024C00004_7529_-NONE-_-NONE-/","piid":"75N91024C00004","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"XUKAM8HMLC71","recipient_name":"SHYNIANBIO INC","recipient_uei":"XUKAM8HMLC71","recipient_cage":"9MSP0","recipient_city":"SAN FRANCISCO","recipient_state":"CA","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-02-13","last_action_date":"2025-02-19","actions":3,"obligated":"299500.00","current_total_value":"299500.00","potential_total_value":"299500.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":34,"description":"PHASE I THERAPEUTIC AWARD - DEVELOPING SPLIT, CONDITIONALLY ACTIVE PEPTIDOMIMETICS OF IL-12 FOR THE TREATMENT OF RARE PEDIATRIC DIPG","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}